What is the level of liabilities of Yield10 Bioscience this year?
Yield10 Bioscience has a debt balance of 6.39 M USD this year.
In 2024, Yield10 Bioscience's total liabilities amounted to 6.39 M USD, a 72.7% difference from the 3.7 M USD total liabilities in the previous year.
Yield10 Bioscience's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Yield10 Bioscience's financial stability, operational efficiency, and long-term viability.
By comparing Yield10 Bioscience's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Yield10 Bioscience's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Shifts in Yield10 Bioscience’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Yield10 Bioscience has a debt balance of 6.39 M USD this year.
The liabilities of Yield10 Bioscience have increased by 72.7% increased compared to the previous year.
High liabilities can pose a risk for investors of Yield10 Bioscience, as they can weaken the company's financial position and impair its ability to meet its obligations.
Low liabilities mean that Yield10 Bioscience has a strong financial position and is able to meet its obligations without overburdening its finances.
An increase in liabilities of Yield10 Bioscience can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
A decrease in the liabilities of Yield10 Bioscience can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
Some factors that can influence the liabilities of Yield10 Bioscience include investments, acquisitions, operating costs, and sales development.
The liabilities of Yield10 Bioscience are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
To change its liabilities, Yield10 Bioscience can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
Over the past 12 months, Yield10 Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Yield10 Bioscience is expected to pay a dividend of 0 USD.
The current dividend yield of Yield10 Bioscience is .
Yield10 Bioscience pays a quarterly dividend. This is distributed in the months of .
Yield10 Bioscience paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
Yield10 Bioscience is assigned to the 'Health' sector.
To receive the latest dividend of Yield10 Bioscience from 11/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.
The last dividend was paid out on 11/1/2024.
In the year 2023, Yield10 Bioscience distributed 0 USD as dividends.
The dividends of Yield10 Bioscience are distributed in USD.
The Yield10 Bioscience stock can be added to a savings plan with the following providers: Trade Republic
Our stock analysis for Yield10 Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Yield10 Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.